These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The mitigating effect of para-hydroxycinnamic acid in bleomycin-induced pulmonary fibrosis in mice through targeting oxidative, inflammatory and fibrotic pathways. Hussein ZA; Abu-Raghif AR; Fawzi HA Basic Clin Pharmacol Toxicol; 2024 Jul; 135(1):23-42. PubMed ID: 38745367 [TBL] [Abstract][Full Text] [Related]
3. USP7 Promotes TGF-β1 Signaling by De-Ubiquitinating Smad2/Smad3 in Pulmonary Fibrosis. Tang F; Gong H; Ke T; Yang W; Yang Y; Liu Z Discov Med; 2024 Aug; 36(187):1616-1626. PubMed ID: 39190377 [TBL] [Abstract][Full Text] [Related]
4. Stevioside attenuates bleomycin-induced pulmonary fibrosis by activating the Nrf2 pathway and inhibiting the NF-κB and TGF-β1/Smad2/3 pathways. Hao W; Yu TT; Zuo DZ; Hu HZ; Zhou PP Exp Lung Res; 2023 Nov; 49(1):205-219. PubMed ID: 38044666 [No Abstract] [Full Text] [Related]
5. Cannabidiol suppresses silica-induced pulmonary inflammation and fibrosis through regulating NLRP3/TGF-β1/Smad2/3 pathway. Shao W; Zhang J; Yao Z; Zhao P; Li B; Tang W; Zhang J Int Immunopharmacol; 2024 Dec; 142(Pt A):113088. PubMed ID: 39244899 [TBL] [Abstract][Full Text] [Related]
6. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung. Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807 [TBL] [Abstract][Full Text] [Related]
7. Salidroside protects against bleomycin-induced pulmonary fibrosis: activation of Nrf2-antioxidant signaling, and inhibition of NF-κB and TGF-β1/Smad-2/-3 pathways. Tang H; Gao L; Mao J; He H; Liu J; Cai X; Lin H; Wu T Cell Stress Chaperones; 2016 Mar; 21(2):239-49. PubMed ID: 26577463 [TBL] [Abstract][Full Text] [Related]
8. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways. Lv Q; Wang J; Xu C; Huang X; Ruan Z; Dai Y Mol Med; 2020 May; 26(1):49. PubMed ID: 32448163 [TBL] [Abstract][Full Text] [Related]
9. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation. Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992 [TBL] [Abstract][Full Text] [Related]
11. Arenaria kansuensis attenuates pulmonary fibrosis in mice via the activation of Nrf2 pathway and the inhibition of NF-kB/TGF-beta1/Smad2/3 pathway. Cui Y; Xin H; Tao Y; Mei L; Wang Z Phytother Res; 2021 Feb; 35(2):974-986. PubMed ID: 32996197 [TBL] [Abstract][Full Text] [Related]
12. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway. Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376 [TBL] [Abstract][Full Text] [Related]
13. Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis. Kanemaru R; Takahashi F; Kato M; Mitsuishi Y; Tajima K; Ihara H; Hidayat M; Wirawan A; Koinuma Y; Hayakawa D; Yagishita S; Ko R; Sato T; Harada N; Kodama Y; Nurwidya F; Sasaki S; Niwa SI; Takahashi K Lung; 2018 Oct; 196(5):531-541. PubMed ID: 29926178 [TBL] [Abstract][Full Text] [Related]
14. Protective effects of microbial biosurfactants produced by Bacillus halotolerans and Candida parapsilosis on bleomycin-induced pulmonary fibrosis in mice: Impact of antioxidant, anti-inflammatory and anti-fibrotic properties via TGF-β1/Smad-3 pathway and miRNA-326. Mousa AM; Nooman MU; Abbas SS; Gebril SM; Abdelraof M; Al-Kashef AS Toxicol Appl Pharmacol; 2024 May; 486():116939. PubMed ID: 38643951 [TBL] [Abstract][Full Text] [Related]
15. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658 [TBL] [Abstract][Full Text] [Related]
16. Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis. Abd-Elmawla MA; Ghaiad HR; Gad ES; Ahmed KA; Abdelmonem M J Zhejiang Univ Sci B; 2023 Jul; 24(8):723-733. PubMed ID: 37551558 [TBL] [Abstract][Full Text] [Related]
17. Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway. Jia L; Sun P; Gao H; Shen J; Gao Y; Meng C; Fu S; Yao H; Zhang G J Pharm Pharmacol; 2019 Jun; 71(6):1017-1028. PubMed ID: 30847938 [TBL] [Abstract][Full Text] [Related]
18. Ginkgo biloba Extract 50 (GBE50) Exerts Antifibrotic and Antioxidant Effects on Pulmonary Fibrosis in Mice by Regulating Nrf2 and TGF-β1/Smad Pathways. Liang W; Yang H; Pan L; Wei S; Li Z; Zhang P; Li R; Wu Y; Liu M; Liu X Appl Biochem Biotechnol; 2024 Aug; 196(8):4807-4822. PubMed ID: 37971580 [TBL] [Abstract][Full Text] [Related]
19. YY1 mediates TGF-β1-induced EMT and pro-fibrogenesis in alveolar epithelial cells. Zhang C; Zhu X; Hua Y; Zhao Q; Wang K; Zhen L; Wang G; Lü J; Luo A; Cho WC; Lin X; Yu Z Respir Res; 2019 Nov; 20(1):249. PubMed ID: 31703732 [TBL] [Abstract][Full Text] [Related]
20. Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation. Chen G; Li J; Liu H; Zhou H; Liu M; Liang D; Meng Z; Gan H; Wu Z; Zhu X; Han P; Liu T; Gu R; Liu S; Dou G Molecules; 2023 Jan; 28(2):. PubMed ID: 36677811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]